Skip to main content
Fig. 1 | Inflammation and Regeneration

Fig. 1

From: Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study

Fig. 1

Clinical study design. Five subjects were screened, and none of them were screen failures. Five subjects were enrolled in the study and received 250 nM of GUT-1 at week 0 (baseline), 2 and 4. Endoscopy was done in all patients at week 0, 2, 4 and 6 for induction regimen and at appropriate time points during follow-up period for up to 52 weeks

Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us